Avβ3 integrin: Pathogenetic role in osteotropic tumors.

Area of Science:

• Oncology
• Cell Biology
• Cancer Metastasis

Background:

• Cancer cell interactions within the tumor microenvironment regulate proliferation, migration, and bone colonization.
• Osteotropism, the tendency of tumor cells to metastasize to bone, involves chemokine signaling, soluble factors, and gene expression within the metastatic niche.
• Osteoclast function is crucial in bone resorption, facilitating the metastatic process.

Purpose of the Study:

• To review the role of alpha-v-beta-3 (αvβ3) integrin signaling in malignant osteoclastogenesis.
• To explore the potential of targeting αvβ3 to restrain bone colonization by skeleton-invading cancers.
• To summarize the implications of αvβ3 signaling in enhancing osteotropism of breast and prostate cancers and multiple myeloma.

Main Methods:

• Review of existing literature on cancer cell-extracellular matrix interactions.
• Analysis of the role of integrins, specifically αvβ3, in cancer cell invasiveness and angiogenesis.
• Examination of studies targeting αvβ3 in various cancer models to assess its impact on tumor progression and survival.

Main Results:

• Integrin αvβ3 regulates cancer cell adhesion to the extracellular matrix, enhancing invasiveness, pro-tumor angiogenesis, and skeletal invasion.
• αvβ3 signaling is implicated in the osteotropism of breast and prostate cancers, as well as multiple myeloma.
• Targeting αvβ3 has demonstrated potential in restraining tumor progression, reducing tumor burden, and improving overall survival in preclinical cancer models.

Conclusions:

• αvβ3 integrin plays a significant role in promoting cancer cell bone metastasis and osteoclastogenesis.
• Targeting αvβ3 represents a promising therapeutic strategy to inhibit bone colonization by metastatic cancers.
• Further research into αvβ3 targeting may lead to improved treatment outcomes for patients with bone-metastasizing cancers.